Salem Capital Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$1.25M Sell
16,377
-200
-1% -$16.6K 0.99% 31
2022
Q2
$1.4M Sell
16,577
-3,417
-17% -$300K 1.02% 30
2022
Q1
$1.75M Hold
19,994
0.98% 31
2021
Q4
$1.75M Sell
19,994
-10,750
-35% -$893K 0.91% 32
2021
Q3
$2.51M Buy
30,744
+22,000
+252% +$1.98M 1.38% 30
2021
Q2
$798K Buy
8,744
+300
+4% +$26.7K 0.44% 47
2021
Q1
$722K Hold
8,444
0.43% 47
2020
Q4
$797K Hold
8,444
0.51% 39
2020
Q3
$734K Hold
8,444
0.53% 41
2020
Q2
$737K Hold
8,444
0.53% 40
2020
Q1
$696K Sell
8,444
-900
-10% -$80.3K 0.58% 38
2019
Q4
$885K Hold
9,344
0.48% 37
2019
Q3
$812K Hold
9,344
0.47% 43
2019
Q2
$853K Sell
9,344
-1,084
-10% -$91.7K 0.47% 44
2019
Q1
$898K Sell
10,428
-624
-6% -$50.1K 0.49% 39
2018
Q4
$850K Sell
11,052
-129
-1% -$10K 0.54% 38
2018
Q3
$863K Buy
11,181
+269
+2% +$19.9K 0.46% 40
2018
Q2
$739K Sell
10,912
-560
-5% -$38.6K 0.4% 45
2018
Q1
$831K Sell
11,472
-196
-2% -$14.9K 0.45% 42
2017
Q4
$878K Buy
11,668
+196
+2% +$14.8K 0.45% 43
2017
Q3
$883K Hold
11,472
0.46% 45
2017
Q2
$858K Hold
11,472
0.48% 44
2017
Q1
$763K Sell
11,472
-2,400
-17% -$160K 0.42% 44
2016
Q4
$905K Sell
13,872
-2,890
-17% -$187K 0.5% 44
2016
Q3
$1.19M Sell
16,762
-12,247
-42% -$892K 0.65% 37
2016
Q2
$2.15M Sell
29,009
-57,579
-66% -$3.98M 1.24% 28
2016
Q1
$5.62M Buy
86,588
+1,534
+2% +$104K 3.16% 13
2015
Q4
$6.56M Hold
85,054
3.71% 9
2015
Q3
$7M Sell
85,054
-3,964
-4% -$353K 4.11% 2
2015
Q2
$7.84M Sell
89,018
-535
-0.6% -$49.1K 4.07% 2
2015
Q1
$7.91M Sell
89,553
-1,585
-2% -$141K 4.02% 2
2014
Q4
$7.57M Sell
91,138
-2,232
-2% -$185K 3.6% 6
2014
Q3
$7.88M Sell
93,370
-6,897
-7% -$558K 3.67% 3
2014
Q2
$8.13M Sell
100,267
-2,684
-3% -$211K 3.61% 3
2014
Q1
$7.84M Sell
102,951
-2,031
-2% -$148K 3.44% 4
2013
Q4
$7.56M Sell
104,982
-670
-0.6% -$46.6K 3.26% 6
2013
Q3
$7.26M Sell
105,652
-1,255
-1% -$83K 3.34% 4
2013
Q2
$6.77M Buy
+106,907
New +$6.96M 3.23% 5

Other funds holding NVS